Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Erythropoietin for neuroprotection in VLBW infants
NCT00589953Phase 2Terminated
- Sponsor
- Atlantic Health System
- Start
- Jul 2007
- Primary completion
- Sep 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of erythropoietin in ischemic stroke, Intraventricular hemorrhage (IVH), periventricular leukomalacia (PVL), sponsored by Atlantic Health System. Started Jul 2007; status: terminated.
02
Drugs
erythropoietin
03
Conditions
ischemic strokeIntraventricular hemorrhage (IVH)periventricular leukomalacia (PVL)
Beyond the preview
Go deeper on NCT00589953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00589953.